Literature DB >> 15858438

Treatment outcome of breast-conserving therapy in patients with positive or close resection margins: Japanese multi institute survey for radiation dose effect.

Kumiko Karasawa1, Michihide Mitsumori, Chikako Yamauchi, Kotaro Gomi, Masaaki Kataoka, Takayoshi Uematsu, Takeshi Kodaira, Michitaka Yamakawa, Katsuyuki Karasawa, Toshikazu Watanabe, Kayoko Tsujino, Masahiro Hiraoka.   

Abstract

BACKGROUND: The relationship between a positive resection margin and the risk of ipsilateral breast tumor recurrence (IBTR) is controversial. To evaluate the radiation dose and other factors influencing the ipsilateral breast tumor control (IBTC) in patients with positive or close resection margins after breast conserving surgery (BCS), the Japanese Radiation Oncology Study Group (JROSG) S-99-3 study group conducted a multi-institute survey of these patients.
METHODS: The patients with less than 5 mm tumor-free margins after BCS were eligible for this study. A total of 971 patients from 18 institutes were enrolled in the analysis. The final pathological margin status was classified into 3 groups. Radiation doses to the tumor bed were less than 60 Gy in 252 patients, 60 Gy in 456 patients and more than 60 Gy in 233 patients.
RESULTS: IBTR was observed in 55 patients (5.8%). The IBTC rates at 5 and 10 years by the Kaplan Meier method were 95.6% and 87.3%, respectively. There was no significant difference in 10-year IBTC rates according to marginal status; 85.9% in positive margin patients, 91.0% in equal or less than 2 mm margin patients and 87.0% in 2.1-5 mm margin patients. Radiation dose to the tumor bed was a marginally significantly associated with the 10-year IBTC rate (> or = 60 Gy 90.8% vs < 60 Gy 84.2%, p = 0.057). In patients with positive margins, IBTC with radiation dose equal to or more than 60 Gy was significantly better (p = 0.039). The other factors influencing the IBTC were age (> or = 35 years vs < 35 years: p < 0.0001), menopausal status (p < 0.0001) and tumor size (p = 0.023).
CONCLUSIONS: In patients with positive margins, IBTC with radiation dose equal to or more than 60 Gy was significantly better than the others. We recommend that the tumor bed be irradiated with at least 60 Gy in the patients with positive margins. Further follow-up is necessary to draw final conclusions.

Entities:  

Mesh:

Year:  2005        PMID: 15858438     DOI: 10.2325/jbcs.12.91

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  6 in total

1.  Efficacy of intraoperative entire-circumferential frozen section analysis of lumpectomy margins during breast-conserving surgery for breast cancer.

Authors:  Tomofumi Osako; Reiki Nishimura; Yasuyuki Nishiyama; Yasuhiro Okumura; Rumiko Tashima; Masahiro Nakano; Mamiko Fujisue; Yasuo Toyozumi; Nobuyuki Arima
Journal:  Int J Clin Oncol       Date:  2015-04-09       Impact factor: 3.402

2.  Role of 10-Gy boost radiation after breast-conserving surgery for stage I-II breast cancer with a 5-mm negative margin.

Authors:  Masafumi Notani; Nobue Uchida; Hajime Kitagaki
Journal:  Int J Clin Oncol       Date:  2007-08-20       Impact factor: 3.402

3.  The association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy: a meta-analysis.

Authors:  Nehmat Houssami; Petra Macaskill; M Luke Marinovich; Monica Morrow
Journal:  Ann Surg Oncol       Date:  2014-01-29       Impact factor: 5.344

Review 4.  Preoperative localization and surgical margins in conservative breast surgery.

Authors:  F Corsi; L Sorrentino; D Bossi; A Sartani; D Foschi
Journal:  Int J Surg Oncol       Date:  2013-08-05

5.  Surgical outcome of patients with core-biopsy-proven nonpalpable breast carcinoma: a large cohort follow-up study.

Authors:  S van Esser; N H G M Peters; M A A J van den Bosch; W P Th M Mali; P H M Peeters; I H M Borel Rinkes; R van Hillegersberg
Journal:  Ann Surg Oncol       Date:  2009-05-13       Impact factor: 5.344

6.  Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.

Authors:  Young Jin Choi; Young Duck Shin; Young Jin Song
Journal:  World J Surg Oncol       Date:  2016-04-27       Impact factor: 2.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.